Temporal Trends in Parkinson's Disease Related Mortality from 1999-2020: A National Analysis.

Balamrit Singh Sokhal, Sowmya Prasanna Kumar Menon, Thomas Shepherd, Sara Muller, Amit Arora, Christian Mallen
Author Information
  1. Balamrit Singh Sokhal: School of Medicine, Keele University, Keele, England, UK. ORCID
  2. Sowmya Prasanna Kumar Menon: School of Medicine, Keele University, Keele, England, UK.
  3. Thomas Shepherd: School of Medicine, Keele University, Keele, England, UK.
  4. Sara Muller: School of Medicine, Keele University, Keele, England, UK. ORCID
  5. Amit Arora: School of Medicine, Keele University, Keele, England, UK.
  6. Christian Mallen: School of Medicine, Keele University, Keele, England, UK. ORCID

Abstract

Introduction: Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is associated with significant disability. The prevalence is rising, and studies have reported potential sex and race disparities in patient outcomes. Data about the demographic trends in PD-related mortality in the United States (US) is limited. This descriptive study aimed to report the national demographic trends in PD-related mortality over a 20-year period.
Methods: The US Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC-WONDER) Underlying Cause of Death database from January 1999 to December 2020 was used to determine the PD-related age adjusted mortality rate (AAMR) stratified by age, sex, ethnicity and geographic area, with the 1999 deaths as the reference group. Annual percentage change (APC) for AAMR was then calculated using Joinpoint regression.
Results: There were 515,884 PD-related deaths in the study period. The AAMR increased from 5.3 per 100,000 population in 1999 to 9.8 per 100,000 in 2020. Males had consistently higher AAMR than females and white race had consistently higher overall AAMR (7.6 per 100,000), followed by American Indians/Alaska Natives (4.4 per 100,000), Asians/Pacific Islanders (4.1 per 100,000) and Black/African Americans (3.4 per 100,000). The Midwest had the highest AAMR followed by West, South and Northeast. Utah, Idaho and Minnesota had the highest state-level AAMR.
Conclusions: This study identified significant age, sex, race and geographic disparities in PD-related mortality in the US. Older age, male sex, white race and Midwest locality were associated with the highest AAMR.

Keywords

References

  1. Neurology. 1989 Sep;39(9):1187-90 [PMID: 2771070]
  2. Am J Cardiol. 2020 Dec 1;136:56-61 [PMID: 32941821]
  3. Stat Med. 2000 Feb 15;19(3):335-51 [PMID: 10649300]
  4. Am J Epidemiol. 1995 Oct 15;142(8):820-7 [PMID: 7572958]
  5. NPJ Parkinsons Dis. 2020 Jul 9;6:15 [PMID: 32665974]
  6. Clinics (Sao Paulo). 2022 Oct 1;77:100121 [PMID: 36194924]
  7. Mov Disord. 2017 Jul;32(7):983-990 [PMID: 28520211]
  8. Front Neurol. 2022 Oct 04;13:956440 [PMID: 36267881]
  9. Ageing Res Rev. 2014 Mar;14:19-30 [PMID: 24503004]
  10. J Am Heart Assoc. 2020 Nov 3;9(21):e017433 [PMID: 33070675]
  11. Neurology. 2021 Nov 16;97(20):e1986-e1993 [PMID: 34706971]
  12. Sci Rep. 2022 Jan 11;12(1):526 [PMID: 35017548]
  13. Mov Disord. 2014 Nov;29(13):1583-90 [PMID: 24976103]
  14. Age Ageing. 2010 Mar;39(2):156-61 [PMID: 20051606]
  15. Am J Public Health. 2018 Mar;108(3):e1-e11 [PMID: 29412713]
  16. Neoreviews. 2019 Oct;20(10):e561-e574 [PMID: 31575778]
  17. Front Neuroendocrinol. 2014 Aug;35(3):370-84 [PMID: 24607323]
  18. J Am Coll Cardiol. 2023 May 2;81(17):1743-1745 [PMID: 37100492]
  19. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808 [PMID: 32576618]
  20. Eur Respir J. 2014 Oct;44(4):1055-68 [PMID: 25142482]
  21. Neuroepidemiology. 2010;34(3):143-51 [PMID: 20090375]
  22. Oral Oncol. 2020 Mar;102:104555 [PMID: 32006782]
  23. Parkinsons Dis. 2015;2015:959304 [PMID: 26819798]
  24. Neurohospitalist. 2023 Apr;13(2):144-152 [PMID: 37064936]
  25. Cureus. 2023 Jul 10;15(7):e41627 [PMID: 37565131]
  26. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):552-562 [PMID: 36522462]
  27. MMWR Morb Mortal Wkly Rep. 2017 May 05;66(17):444-456 [PMID: 28472021]
  28. Lancet Healthy Longev. 2024 Jul;5(7):e464-e479 [PMID: 38945129]
  29. J Am Med Inform Assoc. 1994 Jul-Aug;1(4):303-12 [PMID: 7719813]
  30. Epidemiology. 2007 Nov;18(6):800-4 [PMID: 18049194]
  31. J Parkinsons Dis. 2019;9(3):501-515 [PMID: 31282427]
  32. Arch Neurol. 2012 May;69(5):601-7 [PMID: 22213411]
  33. Eur J Neurol. 2020 Jan;27(1):27-42 [PMID: 31631455]

Word Cloud

Created with Highcharts 10.0.0AAMRper100000PD-relatedsexracemortalityage4USstudyDisease1999highestParkinson'sassociatedsignificantdisparitiesDatademographictrendsperiod2020geographicdeaths3consistentlyhigherwhitefollowedMidwestMortalityIntroduction:diseasePDcommonneurodegenerativemovementdisorderdisabilityprevalencerisingstudiesreportedpotentialpatientoutcomesUnitedStateslimiteddescriptiveaimedreportnational20-yearMethods:CentersControlPreventionWide-RangingOnlineEpidemiologicalResearchCDC-WONDERUnderlyingCauseDeathdatabaseJanuaryDecemberuseddetermineadjustedratestratifiedethnicityareareferencegroupAnnualpercentagechangeAPCcalculatedusingJoinpointregressionResults:515884increased5population98Malesfemalesoverall76AmericanIndians/AlaskaNativesAsians/PacificIslanders1Black/AfricanAmericansWestSouthNortheastUtahIdahoMinnesotastate-levelConclusions:identifiedOldermalelocalityTemporalTrendsRelated1999-2020:NationalAnalysisParkinson’sOutcomesEpidemiology

Similar Articles

Cited By